Literature DB >> 23180243

Ectoenzymes and cholinesterase activity and biomarkers of oxidative stress in patients with lung cancer.

Daniela Zanini1, Roberta Schmatz, Luana Paula Pelinson, Victor Camera Pimentel, Pauline da Costa, Andréia Machado Cardoso, Caroline Curry Martins, Christina Chitolina Schetinger, Jucimara Baldissareli, Maria do Carmo Araújo, Liliane Oliveira, Juarez Chiesa, Vera Maria Morsch, Daniela Bitencourt Rosa Leal, Maria Rosa Chitolina Schetinger.   

Abstract

We aimed to examine the nucleoside triphosphate diphosphohydrolases (NTPDase) in lymphocytes; adenosine deaminase (ADA) and butyrylcholinesterase (BChE) in serum; and acetylcholinesterase (AChE), superoxide dismutase (SOD), and catalase (CAT) activity in whole blood; since these enzymes are involved in inflammation responses as well as in oxidative stress conditions. We also checked the levels of total thiols (T-SH), non-protein thiols (NPSH), and thiobarbituric acid reactive substances (TBARS) in serum of patients with lung cancer. We collected blood samples from patients (n = 31) previously treated for lung cancer with chemotherapy. Patients were classified as stage IIIb and IV according to the Union for International Cancer Control (UICC). The results showed a significant increase in the hydrolysis of ATP, ADP, and adenosine in patients when compared with the control group. The activity of AChE, SOD, and CAT as well as the T-SH and NPSH levels were higher in patients group and TBARS levels were lower in patients compared with the control group. These findings demonstrated that the enzymes activity involved in the control of inflammatory and immune processes as well as the oxidative stress parameters are altered in patients with lung cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180243     DOI: 10.1007/s11010-012-1513-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  58 in total

Review 1.  Mechanisms of pulmonary fibrosis.

Authors:  Victor J Thannickal; Galen B Toews; Eric S White; Joseph P Lynch; Fernando J Martinez
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

2.  A direct colorimetric assay for Ca2+ -stimulated ATPase activity.

Authors:  K M Chan; D Delfert; K D Junger
Journal:  Anal Biochem       Date:  1986-09       Impact factor: 3.365

3.  Autonomic neural regulation of immunity.

Authors:  C J Czura; K J Tracey
Journal:  J Intern Med       Date:  2005-02       Impact factor: 8.989

4.  Characterization of NTPDase (NTPDase1; ecto-apyrase; ecto-diphosphohydrolase; CD39; EC 3.6.1.5) activity in human lymphocytes.

Authors:  Daniela B R Leal; Cristiane A Streher; Tiago N Neu; Fábio P Bittencourt; Cláudio A M Leal; José E P da Silva; Vera M Morsch; Maria R C Schetinger
Journal:  Biochim Biophys Acta       Date:  2004-10-06

5.  Improved analysis of malondialdehyde in human body fluids.

Authors:  A M Jentzsch; H Bachmann; P Fürst; H K Biesalski
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

6.  Adenosine deaminase activity in the serum and malignant tumors of breast cancer: the assessment of isoenzyme ADA1 and ADA2 activities.

Authors:  Mahmood Aghaei; Fatemeh Karami-Tehrani; Siamak Salami; Morteza Atri
Journal:  Clin Biochem       Date:  2005-10       Impact factor: 3.281

7.  Oxidative stress in non-small cell lung cancer patients after chemotherapy: association with treatment response.

Authors:  Abhilasha Gupta; Shruti Srivastava; Rajendra Prasad; Shanker M Natu; Balraj Mittal; Mahendra P S Negi; Anand N Srivastava
Journal:  Respirology       Date:  2010-02       Impact factor: 6.424

Review 8.  The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment.

Authors:  Alexander Greenhough; Helena J M Smartt; Amy E Moore; Heather R Roberts; Ann C Williams; Christos Paraskeva; Abderrahmane Kaidi
Journal:  Carcinogenesis       Date:  2009-01-09       Impact factor: 4.944

9.  [Lung cancer in Spain. Current epidemiology, survival, and treatment].

Authors:  Julio Sánchez De Cos Escuín
Journal:  Arch Bronconeumol       Date:  2009-03-25       Impact factor: 4.872

10.  The relationship between fatty acid peroxidation and alpha-tocopherol consumption in isolated normal and transformed hepatocytes.

Authors:  P Cogrel; I Morel; G Lescoat; M Chevanne; P Brissot; P Cillard; J Cillard
Journal:  Lipids       Date:  1993-02       Impact factor: 1.880

View more
  17 in total

1.  Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.

Authors:  Amel Ben Anes; Hela Ben Nasr; Abdelhamid Garrouch; Sarra Bennour; Sarra Bchir; Mohamed Hachana; Mohamed Benzarti; Zouhair Tabka; Karim Chahed
Journal:  Mol Cell Biochem       Date:  2017-12-12       Impact factor: 3.396

2.  Ketoprofen-loaded polymeric nanocapsules selectively inhibit cancer cell growth in vitro and in preclinical model of glioblastoma multiforme.

Authors:  Elita F da Silveira; Janaine M Chassot; Fernanda C Teixeira; Juliana H Azambuja; Gabriela Debom; Fátima T Beira; Francisco A B Del Pino; Adriana Lourenço; Ana P Horn; Letícia Cruz; Roselia M Spanevello; Elizandra Braganhol
Journal:  Invest New Drugs       Date:  2013-09-27       Impact factor: 3.850

3.  Thiol/disulfide homeostasis: A prognostic biomarker for patients with advanced non-small cell lung cancer?

Authors:  Nigar Dirican; Ahmet Dirican; Orhan Sen; Ayse Aynali; Sule Atalay; Haci Ahmet Bircan; Onder Oztürk; Serpil Erdogan; Munire Cakir; Ahmet Akkaya
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

4.  Estimation of Serum Butyryl Cholinesterase in Patients with Oral Squamous Cell Carcinoma: A Cross-Sectional Study.

Authors:  Keerthi K Nair; Gujjar Vittobarao Pramod; Kanad Chaudhuri; Lingappa Ashok
Journal:  J Clin Diagn Res       Date:  2017-07-01

5.  Imatinib mesylate affects extracellular ATP catabolism and expression of NTPDases in a chronic myeloid leukemia cell line.

Authors:  Julia Biz Willig; Débora Renz Barreto Vianna; Aline Beckenkamp; Liziane Raquel Beckenkamp; Jean Sévigny; Márcia Rosângela Wink; Andréia Buffon; Diogo André Pilger
Journal:  Purinergic Signal       Date:  2020-01-18       Impact factor: 3.765

6.  Dysregulated cholinergic network as a novel biomarker of poor prognostic in patients with head and neck squamous cell carcinoma.

Authors:  Ana Cristina Castillo-González; Susana Nieto-Cerón; Juan Pablo Pelegrín-Hernández; María Fernanda Montenegro; José Antonio Noguera; María Fuensanta López-Moreno; José Neptuno Rodríguez-López; Cecilio J Vidal; Diego Hellín-Meseguer; Juan Cabezas-Herrera
Journal:  BMC Cancer       Date:  2015-05-10       Impact factor: 4.430

Review 7.  Role of acetylcholinesterase in lung cancer.

Authors:  Hui-Jun Xi; Ren-Pei Wu; Jing-Jing Liu; Ling-Juan Zhang; Zhao-Shen Li
Journal:  Thorac Cancer       Date:  2015-03-20       Impact factor: 3.500

8.  Effects of nanosilver exposure on cholinesterase activities, CD41, and CDF/LIF-like expression in zebrafish (Danio rerio) larvae.

Authors:  Marzhan Myrzakhanova; Chiara Gambardella; Carla Falugi; Antonietta M Gatti; Grazia Tagliafierro; Paola Ramoino; Paolo Bianchini; Alberto Diaspro
Journal:  Biomed Res Int       Date:  2013-08-06       Impact factor: 3.411

Review 9.  Acetylcholine signaling system in progression of lung cancers.

Authors:  Jamie R Friedman; Stephen D Richbart; Justin C Merritt; Kathleen C Brown; Nicholas A Nolan; Austin T Akers; Jamie K Lau; Zachary R Robateau; Sarah L Miles; Piyali Dasgupta
Journal:  Pharmacol Ther       Date:  2018-10-03       Impact factor: 13.400

Review 10.  Evidence in support of potential applications of lipid peroxidation products in cancer treatment.

Authors:  Omotayo O Erejuwa; Siti A Sulaiman; Mohd S Ab Wahab
Journal:  Oxid Med Cell Longev       Date:  2013-12-04       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.